Eagle Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $332K | Hold |
13,800
| – | – | 0.01% | 232 |
|
|
2026
Q1 | $388K | Hold |
13,800
| – | – | 0.01% | 224 |
|
|
2025
Q4 | $344K | Buy |
13,800
+250
| +2% | +$6.3K | 0.01% | 238 |
|
|
2025
Q3 | $345K | Hold |
13,550
| – | – | 0.01% | 237 |
|
|
2025
Q2 | $328K | Hold |
13,550
| – | – | 0.01% | 227 |
|
|
2025
Q1 | $343K | Hold |
13,550
| – | – | 0.01% | 224 |
|
|
2024
Q4 | $359K | Buy |
+13,550
| New | +$368K | 0.01% | 217 |
|
|
2024
Q3 | – | Sell |
-7,721
| Closed | -$216K | – | 247 |
|
|
2024
Q2 | $216K | Sell |
7,721
-1,002
| -11% | -$27.6K | 0.01% | 227 |
|
|
2024
Q1 | $242K | Sell |
8,723
-1,025
| -11% | -$28.4K | 0.01% | 217 |
|
|
2023
Q4 | $281K | Sell |
9,748
-1,905
| -16% | -$57.6K | 0.02% | 201 |
|
|
2023
Q3 | $387K | Sell |
11,653
-250
| -2% | -$8.84K | 0.03% | 181 |
|
|
2023
Q2 | $437K | Sell |
11,903
-25
| -0.2% | -$973 | 0.03% | 173 |
|
|
2023
Q1 | $487K | Sell |
11,928
-99
| -0.8% | -$4.28K | 0.03% | 162 |
|
|
2022
Q4 | $616K | Sell |
12,027
-491
| -4% | -$23.5K | 0.04% | 153 |
|
|
2022
Q3 | $548K | Sell |
12,518
-117,206
| -90% | -$5.7M | 0.04% | 154 |
|
|
2022
Q2 | $6.8M | Sell |
129,724
-10,868
| -8% | -$554K | 0.5% | 58 |
|
|
2022
Q1 | $7.28M | Sell |
140,592
-467
| -0.3% | -$24.2K | 0.45% | 62 |
|
|
2021
Q4 | $8.33M | Buy |
141,059
+130,215
| +1,201% | +$6.45M | 0.52% | 59 |
|
|
2021
Q3 | $466K | Sell |
10,844
-150
| -1% | -$6.64K | 0.03% | 175 |
|
|
2021
Q2 | $431K | Sell |
10,994
-300
| -3% | -$11.7K | 0.03% | 189 |
|
|
2021
Q1 | $409K | Sell |
11,294
-541
| -5% | -$19.2K | 0.03% | 196 |
|
|
2020
Q4 | $436K | Sell |
11,835
-639
| -5% | -$23.4K | 0.03% | 167 |
|
|
2020
Q3 | $434K | Sell |
12,474
-291
| -2% | -$10.2K | 0.04% | 153 |
|
|
2020
Q2 | $396K | Sell |
12,765
-2,699
| -17% | -$91.7K | 0.04% | 151 |
|
|
2020
Q1 | $479K | Sell |
15,464
-527
| -3% | -$18K | 0.05% | 141 |
|
|
2019
Q4 | $594K | Sell |
15,991
-211
| -1% | -$7.52K | 0.03% | 157 |
|
|
2019
Q3 | $552K | Sell |
16,202
-961
| -6% | -$34.9K | 0.02% | 158 |
|
|
2019
Q2 | $705K | Sell |
17,163
-369
| -2% | -$14.7K | 0.03% | 157 |
|
|
2019
Q1 | $706K | Buy |
17,532
+817
| +5% | +$32.7K | 0.03% | 156 |
|
|
2018
Q4 | $692K | Sell |
16,715
-369
| -2% | -$15.3K | 0.03% | 152 |
|
|
2018
Q3 | $714K | Sell |
17,084
-422
| -2% | -$16.2K | 0.02% | 160 |
|
|
2018
Q2 | $603K | Sell |
17,506
-316
| -2% | -$10.8K | 0.02% | 170 |
|
|
2018
Q1 | $600K | Sell |
17,822
-896
| -5% | -$30.8K | 0.02% | 170 |
|
|
2017
Q4 | $643K | Hold |
18,718
| – | – | 0.02% | 167 |
|
|
2017
Q3 | $634K | Sell |
18,718
-6,661
| -26% | -$214K | 0.02% | 168 |
|
|
2017
Q2 | $809K | Sell |
25,379
-44,376
| -64% | -$1.4M | 0.02% | 161 |
|
|
2017
Q1 | $2.26M | Buy |
69,755
+3,601
| +5% | +$114K | 0.06% | 134 |
|
|
2016
Q4 | $2.04M | Buy |
66,154
+1,172
| +2% | +$35.8K | 0.06% | 133 |
|
|
2016
Q3 | $2.09M | Buy |
64,982
+4,271
| +7% | +$143K | 0.06% | 137 |
|
|
2016
Q2 | $2.03M | Buy |
60,711
+447
| +0.7% | +$14.3K | 0.06% | 139 |
|
|
2016
Q1 | $1.7M | Buy |
60,264
+796
| +1% | +$22.7K | 0.06% | 137 |
|
|
2015
Q4 | $1.82M | Buy |
59,468
+1,924
| +3% | +$60.5K | 0.06% | 137 |
|
|
2015
Q3 | $1.72M | Buy |
57,544
+342
| +0.6% | +$11K | 0.06% | 142 |
|
|
2015
Q2 | $1.82M | Buy |
57,202
+3,189
| +6% | +$104K | 0.05% | 149 |
|
|
2015
Q1 | $1.78M | Buy |
54,013
+643
| +1% | +$20.4K | 0.05% | 145 |
|
|
2014
Q4 | $1.58M | Hold |
53,370
| – | – | 0.04% | 157 |
|
|
2014
Q3 | $1.5M | Sell |
53,370
-1,208
| -2% | -$33.9K | 0.04% | 161 |
|
|
2014
Q2 | $1.54M | Sell |
54,578
-1,366
| -2% | -$38.9K | 0.04% | 151 |
|
|
2014
Q1 | $1.71M | Sell |
55,944
-108,172
| -66% | -$3.23M | 0.05% | 148 |
|
|
2013
Q4 | $4.77M | Sell |
164,116
-4,841
| -3% | -$141K | 0.15% | 113 |
|
|
2013
Q3 | $4.61M | Sell |
168,957
-2,550
| -1% | -$69.4K | 0.16% | 106 |
|
|
2013
Q2 | $4.56M | Buy |
+171,507
| New | +$4.74M | 0.17% | 102 |
|
Other funds holding PFE
Eagle Global Advisors's PFE Position: Q2 2026 in Review
Eagle Global Advisors held its Pfizer (PFE) position steady in Q2 2026 at 13,800 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #232.
Eagle Global Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.33M in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Eagle Global Advisors held 13,800 shares of Pfizer worth $332K as of Q2 2026.
- Eagle Global Advisors left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Eagle Global Advisors's portfolio in Q2 2026, its #232 holding.
- Eagle Global Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Eagle Global Advisors's Pfizer position peaked at $8.33M in Q4 2021.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.